Coccidioidomycosis in Patients Treated With Ruxolitinib.
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Coccidioidomycosis in Patients Treated With Ruxolitinib.

Kusne, Yael;Kimes, Kathryn E;Feller, Fionna F;Patron, Roberto;Banacloche, Juan Gea;Blair, Janis E;Vikram, Holenarasipur R;Ampel, Neil M;
Open forum infectious diseases 2020 Vol. 7 pp. ofaa167
156
kusne2020coccidioidomycosisopen

Abstract

We report 8 cases of coccidioidomycosis associated with ruxolitinib treatment. Among 135 patients living in the coccidioidal-endemic region receiving ruxolitinib, 5 cases were diagnosed after starting and 4 had extrathoracic dissemination. Periodic serological screening while on ruxolitinib is warranted for patients residing in the coccidioidal-endemic region.

Keywords

fungal infections ruxolitinib coccidioidomycosis immunocompromised host

Access

DOI:
10.1093/ofid/ofaa167

Citation

ID: 108013
Ref Key: kusne2020coccidioidomycosisopen
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
108013
Unique Identifier:
10.1093/ofid/ofaa167
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store